We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Saillant Therapeutics, an innovative biotechnology start-up, developing promising small molecule-based therapies, today announced the swift advancement of an innovative groundbreaking generic virus-inhibiting treatment platform based on activation of a c